Clinical Trial Detail

NCT ID NCT01038778
Title Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

clear cell renal cell carcinoma

Therapies

Entinostat

Aldesleukin

Age Groups: adult

No variant requirements are available.